Related Experiment Video
Updated: Jan 1, 2026

21:55
Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
Published on: April 2, 2012
29.0K
Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2
Antonette Bennett1, Annahita Keravala2, Victoria Makal1
1Department of Biochemistry and Molecular Biology, Center for Structural Biology, McKnight Brain Institute, College of Medicine, University of Florida, 1200 Newell Drive, Gainesville, FL 32610, USA.
Journal of Structural Biology
|December 21, 2019
Summary
The engineered AAV2.7m8 vector, with a novel capsid insertion, efficiently targets retina cells. Structural analysis reveals key differences from AAV2, explaining its altered antigenic properties and improved transduction capabilities.
Area of Science:
- Structural Biology
- Virology
- Gene Therapy
Background:
- Adeno-associated virus (AAV) vectors are crucial for gene therapy, particularly for retinal diseases.
- AAV2.7m8 is an engineered AAV variant designed for enhanced retinal transduction via intravitreal injection.
- Understanding structural modifications is key to optimizing AAV vector design.
Purpose of the Study:
- To elucidate the structural differences between the engineered AAV2.7m8 vector and its parental AAV2 serotype.
- To correlate structural changes with the altered antigenic properties and improved tropism of AAV2.7m8.
- To provide insights for future rational design of AAV vectors.
Main Methods:
- Cryo-electron microscopy (cryo-EM) and image reconstruction were employed to determine high-resolution structures.
- Structures of recombinant AAV2.7m8 (rAAV2.7m8) and AAV2 were resolved to 2.91 Å and 3.02 Å, respectively.
- Comparative analysis focused on capsid surface variable region VIII (VR-VIII) and amino acid side-chain configurations.
Main Results:
- The 10-amino acid insertion in AAV2.7m8's VR-VIII was localized, though side-chain details were limited by flexibility.
- Structural comparison revealed distinct side-chain orientations in AAV2.7m8 compared to AAV2, particularly within the modified VR-VIII region.
- These structural variations in VR-VIII, an antigenic epitope, correlate with AAV2.7m8's ability to evade the C37-B monoclonal antibody.
Conclusions:
- The structural basis for AAV2.7m8's altered antigenic profile and enhanced retinal transduction is identified.
- Cryo-EM provides valuable data on the impact of surface peptide insertions on AAV capsid structure.
- Findings support rational design strategies for developing next-generation AAV vectors with tailored tropism and immune evasion properties.

